Financials Ardelyx, Inc.

Equities

ARDX

US0396971071

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-05-31 pm EDT 5-day change 1st Jan Change
6.855 USD +1.11% Intraday chart for Ardelyx, Inc. +1.56% +10.56%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 644 583.9 124 534.3 1,439 1,605 - -
Enterprise Value (EV) 1 445.3 583.9 124 534.3 1,439 1,605 1,605 1,605
P/E ratio -5.11 x -6.16 x -0.72 x -6.79 x -20.7 x -20 x 57.9 x 8.98 x
Yield - - - - - - - -
Capitalization / Revenue 122 x 77.1 x 12.3 x 10.2 x 11.6 x 6.53 x 4.05 x 2.71 x
EV / Revenue 122 x 77.1 x 12.3 x 10.2 x 11.6 x 6.53 x 4.05 x 2.71 x
EV / EBITDA -7.26 x -6.56 x -0.88 x -10.3 x -29.7 x -29.3 x 17.8 x 5.69 x
EV / FCF -8.38 x -7.14 x -0.8 x -7.62 x - -22 x 42.8 x 8.45 x
FCF Yield -11.9% -14% -125% -13.1% - -4.54% 2.34% 11.8%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 85,807 90,248 112,743 187,460 232,138 233,977 - -
Reference price 2 7.505 6.470 1.100 2.850 6.200 6.860 6.860 6.860
Announcement Date 3/6/20 3/8/21 2/28/22 3/2/23 2/22/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 5.281 7.571 10.1 52.16 124.5 245.7 396.2 593.1
EBITDA 1 -88.76 -88.96 -140.2 -51.86 -48.45 -54.69 90.2 282
EBIT 1 -91.26 -90.78 -154.3 -63.76 -63.28 -73.43 36.26 207.8
Operating Margin -1,728.14% -1,199.05% -1,528.63% -122.24% -50.84% -29.89% 9.15% 35.04%
Earnings before Tax (EBT) 1 -94.94 -94.31 -158.2 -67.2 -65.52 -81.5 28.81 199.9
Net income 1 -94.94 -94.31 -158.2 -67.21 -66.07 -80.51 28.79 192.4
Net margin -1,797.77% -1,245.71% -1,566.46% -128.85% -53.08% -32.77% 7.27% 32.45%
EPS 2 -1.470 -1.050 -1.520 -0.4200 -0.3000 -0.3429 0.1184 0.7637
Free Cash Flow 1 -76.81 -81.76 -154.4 -70.1 - -72.84 37.52 190.1
FCF margin -1,454.44% -1,079.9% -1,529.35% -134.4% - -29.65% 9.47% 32.05%
FCF Conversion (EBITDA) - - - - - - 41.59% 67.41%
FCF Conversion (Net income) - - - - - - 130.33% 98.76%
Dividend per Share 2 - - - - - - - -
Announcement Date 3/6/20 3/8/21 2/28/22 3/2/23 2/22/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 1.029 0.468 2.526 4.986 44.18 11.37 22.33 56.39 34.36 46.02 55.27 66.3 78.09 80.73 91.82
EBITDA 1 -31.45 -23.68 -22.73 -19.63 14.18 -23.15 -13.42 11.18 -23.69 -24.66 -18.78 -11.37 -3.785 - -
EBIT 1 -35.27 -27.81 -26.22 -21.88 12.14 -26.06 -16.62 7.398 -27.99 -24.68 -22.62 -17 -9.139 -9.961 -2.145
Operating Margin -3,427.89% -5,941.67% -1,037.81% -438.83% 27.49% -229.25% -74.44% 13.12% -81.44% -53.62% -40.93% -25.64% -11.7% -12.34% -2.34%
Earnings before Tax (EBT) 1 -36.23 -28.07 -26.93 -22.89 10.7 -26.76 -17.12 6.829 -28.47 -26.4 -24.83 -19.17 -11.35 -11.56 -3.742
Net income 1 -36.23 -28.07 -26.94 -22.89 10.7 -26.77 -17.12 6.629 -28.8 -26.52 -24.55 -19.01 -10.66 -11.77 -4.104
Net margin -3,521.28% -5,998.08% -1,066.43% -459.15% 24.21% -235.49% -76.66% 11.76% -83.82% -57.62% -44.42% -28.67% -13.65% -14.57% -4.47%
EPS 2 -0.3100 -0.2100 -0.1900 -0.1400 0.0600 -0.1300 -0.0800 0.0300 -0.1200 -0.1100 -0.1055 -0.0816 -0.0442 -0.0380 0.004000
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 2/28/22 5/5/22 8/4/22 11/3/22 3/2/23 5/3/23 8/2/23 10/31/23 2/22/24 5/2/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position 199 - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -76.8 -81.8 -154 -70.1 - -72.8 37.5 190
ROE (net income / shareholders' equity) - - -152% -74.3% -49.8% -60.6% 33.5% 86.1%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 0.33 0.32 1.87 0.06 0.34 1.3 1.32 1.35
Capex / Sales 6.15% 4.28% 18.49% 0.11% 0.28% 0.53% 0.33% 0.23%
Announcement Date 3/6/20 3/8/21 2/28/22 3/2/23 2/22/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
6.86 USD
Average target price
13.83 USD
Spread / Average Target
+101.59%
Consensus
  1. Stock Market
  2. Equities
  3. ARDX Stock
  4. Financials Ardelyx, Inc.